Prevalence of Obesity, Dyslipidemia and Diabetes Mellitus in Patients with Gastrojejunostomy
Introduction: Billroth Gastrojejunostomy (GJ) is less invasive surgery as compared to Roux-en-Y Gastric Bypass (RYGB), which is performed for obesity and weight loss. There is sparse data on long term metabolic effects of GJ, which was performed frequently in the past. Aim: To determine the pre...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/14871/45195_CE[Ra]_F(Sh)_PF1(SC_RK)_PFA(SC_KM)_PN(KM).pdf |
Summary: | Introduction: Billroth Gastrojejunostomy (GJ) is less invasive
surgery as compared to Roux-en-Y Gastric Bypass (RYGB),
which is performed for obesity and weight loss. There is sparse
data on long term metabolic effects of GJ, which was performed
frequently in the past.
Aim: To determine the prevalence of obesity, dyslipidemia and
Diabetes Mellitus (DM) in patients that had undergone GJ.
Materials and Methods: This was a cross-sectional study
conducted in the Department of Gastroenterology, Government
Medical College, Calicut, Kerala, India, over a period of six
years. All patients with history of GJ, done in past 15 years were
included in the study. Presence of obesity, DM and dyslipidemia
were noted among patients and was compared with their first
degree relatives. Patients with family history of diabetes and
without first degree relative were excluded from the study.
Statistical analysis was performed using Chi-square test for
qualitative variables and independent t-test for quantitative
variables. Significance level was fixed as p-value of <0.05.
Results: A total of 68 patients were studied. Mean age of
patients was 64.01±10.2 years with males predominating
the population (92.6%). The most common three reasons for
presentation in gastroenterology were dyspeptic symptoms
32(47%), evaluation of anaemia 12 (17.6%), and history of
malena 10(14.7%). Prevalence of diabetes was significantly
less in patients with GJ (2.9% vs 22%). Obesity and
dyslipidemia was also common in patients without GJ (7.3%),
with p-value <0.05.
Conclusion: Prevalence of obesity, DM and dyslipidemia is
significantly lower in patients with GJ. |
---|---|
ISSN: | 2249-782X 0973-709X |